Over the last 12 months, Dolby Laboratories insiders reported no purchases and 5 sales totaling $2.0M across SEC Form 4 filings. 60% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Nicholson RyanVP, CAO and Corp. Controller · O | ▼ Sale | 357 | $60.63 | $22K | -1% | — |
| Aug 3, 2026 | Couling John DSVP, Entertainment · O | ▼ Sale | 7,667 | $60 | $460K | -6.1% | plan · 2 tranches |
| Jul 1, 2026 | Couling John DSVP, Entertainment · O | ▼ Sale | 7,667 | $53.2 | $408K | -6.1% | plan |
| Jun 1, 2026 | Couling John DSVP, Entertainment · O | ▼ Sale | 7,666 | $55.62 | $426K | -6.1% | plan · 2 tranches |
| May 22, 2026 | Pendleton ToddSVP, Chief Marketing Officer · O | ▼ Sale | 11,876 | $54.55 | $648K | -22.3% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $DLB feed.